Superworth

Nomad Power Solutions EPS NMAD

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.99
Latest quarter, Q2 FY26
−$0.16
Fiscal year 2025
−$1.23

Nomad Power Solutions' earnings per share was −$0.99 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.16.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.23n/a
FY2024−$1.59n/a
FY2023−$2.77n/a
FY2022n/an/a
FY2021−$5.10n/a
FY2020−$2.80n/a
FY2019−$2.40n/a
FY2018−$3.00n/a
FY2017−$2.40n/a
FY2016−$2.40n/a
FY2015−$3.60n/a
FY2014−$3.60n/a
FY2013−$2.40n/a
FY2012−$6.00n/a
FY2011−$3.60n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.16n/a−$0.99
Q1 FY26−$0.18n/a−$1.12
Q4 FY25−$0.32n/a−$1.23
Q3 FY25−$0.33n/a−$1.18
Q2 FY25−$0.29n/a−$1.29
Q1 FY25−$0.29n/a−$1.45
Q4 FY24−$0.27n/a−$1.59
Q3 FY24−$0.44n/a−$1.78
Q2 FY24−$0.45n/a−$1.83
Q1 FY24−$0.43n/a−$2.38
Q4 FY23−$0.46n/a−$2.77
Q3 FY23−$0.49n/a−$3.29

Against its peers

Companies in Drug Manufacturers - General nearest Nomad Power Solutions' size, closest first, today.

CompanyEPS, 12 monthsGrowth
NMADNomad Power Solutions−$0.99
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
ATNMActinium Pharmaceuticals$0.36
NATRNatures Sunshine Products$1.01+36% a year
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
Peer median$0.52

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Nomad Power Solutions

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.